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ABSTRACT
Background
Maternal mortality is a major health problem concentrated in resource-poor regions.
Accurate data on its causes using rigorous methods is lacking, but is essential to guide policy-
makers and health professionals to reduce this intolerable burden. The aim of this study was to
accurately describe the causes of maternal death in order to contribute to its reduction, in one
of the regions of the world with the highest maternal mortality ratios.
Methods and Findings
We conducted a prospective study between October 2002 and December 2004 on the
causes of maternal death in a tertiary-level referral hospital in Maputo, Mozambique, using
complete autopsies with histological examination. HIV detection was done by virologic and
serologic tests, and malaria was diagnosed by histological and parasitological examination.
During 26 mo there were 179 maternal deaths, of which 139 (77.6%) had a complete autopsy
and formed the basis of this analysis. Of those with test results, 65 women (52.8%) were HIV-
positive. Obstetric complications accounted for 38.2% of deaths; haemorrhage was the most
frequent cause (16.6%). Nonobstetric conditions accounted for 56.1% of deaths; HIV/AIDS,
pyogenic bronchopneumonia, severe malaria, and pyogenic meningitis were the most
common causes (12.9%, 12.2%, 10.1% and 7.2% respectively). Mycobacterial infection was
found in 12 (8.6%) maternal deaths.
Conclusions
In this tertiary hospital in Mozambique, infectious diseases accounted for at least half of all
maternal deaths, even though effective treatment is available for the four leading causes, HIV/
AIDS, pyogenic bronchopneumonia, severe malaria, and pyogenic meningitis. These
observations highlight the need to implement effective and available prevention tools, such
as intermittent preventive treatment and insecticide-treated bed-nets for malaria, antiretroviral
drugs for HIV/AIDS, or vaccines and effective antibiotics for pneumococcal and meningococcal
diseases. Deaths due to obstetric causes represent a failure of health-care systems and require
urgent improvement.
The Editors’ Summary of this article follows the references.
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Every year approximately 250,000 African women die during
pregnancy, delivery, or the puerperium, but we know very little
of the causes of these deaths. In Africa maternal mortality
ratios (number of maternal deaths per 100,000 live births) are
more than 100 times higher than those in the developed world
[1], and the international community has included the
reduction of maternal mortality by three-quarters by 2015 as
one of the targets of the Millennium Development Goals [2].
However, efforts to reduce maternal mortality in Africa are
not being driven by evidence. In developing countries the main
source of information on the causes of maternal death is
clinical records and verbal autopsies [2–10]. Both sources have
substantial limitations due to discrepancies between the
clinically presumed and the actual cause of death [11].
Information provided by medical autopsies has played an
important role in increasing the accuracy of cause-of-death
reports and improving clinical practice in the developed world
[11,12]. Autopsies may also provide important data on the
causes of maternal death, an essential component to reducing
maternal mortality and to directing public health efforts.
According to available information, obstetric complica-
tions are the most frequent causes of maternal mortality in
developing countries [2,6–8,13]. In the last two decades the
HIV/AIDS epidemic has become a major health problem in
sub-Saharan Africa [14], but its impact on maternal mortality
has been poorly investigated [15]. Similarly, little is known on
the possible impact of severe malaria [16,17] and other
infectious diseases. Recent evidence suggests that HIV
infection increases the risk of malaria among pregnant
women [18], but the possible effect of this interaction on
mortality has not been evaluated.
In order to accurately determine the causes of maternal
death in a tertiary-level referral hospital in a country in sub-
Saharan Africa, we conducted a prospective, descriptive study
in Maputo, Mozambique, that included complete autopsies.
Methods
Study Area
The study was conducted at the Maputo Central Hospital,
between October 2002 and December 2004. The Maputo
Central Hospital is a government-funded tertiary care
facility, and serves as the referral centre for other hospitals
in Southern Mozambique. Malaria transmission in the
Maputo urban and suburban areas is low [19], while the
surrounding rural areas have moderate and stable trans-
mission. The reported HIV seroprevalence in pregnant
women for 2004 was 16.2% as the average for the country,
and 20.7% for the Maputo area (unpublished data, Ministry
of Health, Mozambique, 2004).
Study Design
This was a prospective, descriptive study that included all
consecutive deaths fulﬁlling the standard deﬁnition of the
World Health Organization (WHO) for a maternal death. We
included all women dying during pregnancy or within 42 d of
completion of a pregnancy, irrespective of the cause of death,
and for whom the family had given verbal (oral) informed
consent. A standardized questionnaire to collect demo-
graphic, clinical, and obstetric data was administered by
trained health personnel after a review of the medical
records. All births occurring at the hospital during the study
period were reviewed to estimate the ratio of maternal deaths
to live births among mothers who gave birth at the hospital.
The study protocol was approved by the National Mozambi-
can Ethics Committee and the Hospital Clinic of Barcelona
Ethics Review Committee.
Autopsy and Diagnosis
Maternal deaths underwent a complete dissection with
macroscopic evaluation of each organ by a pathologist (CC,
MRI, or CR) using a standardized macroscopic protocol.
Samples of all grossly identiﬁed lesions and of all viscera were
collected from each woman for histological study. A blood
sample (100 ll) was obtained from the inferior vena cava and
stored on ﬁlter paper.
The ﬁnal diagnoses were established by two pathologists
(CR, JO) after reviewing the histological slides and the
macroscopic and clinical protocols. Clinical and necropsy
diagnoses were grouped into different categories according
to the International Classiﬁcation of Disease, tenth revision
(ICD-10). HIV/AIDS-related diseases included all cases with
opportunistic infections or other conditions included in the
CDC revised criteria [20]. When more than one pathological
diagnosis was identiﬁed, the different diagnoses were
classiﬁed as: (a) main disease causing the death; (b) ﬁnal
event directly causing the death in a patient with a different
main diagnosis (e.g., aspiration pneumonia in a woman with
eclampsia causing a cerebral haemorrhage); (c) secondary
lesions possibly contributing to the death (e.g., past malaria
diagnosed because of macrophages with haemozoin in liver
and spleen in a patient dying of meningitis); and (d)
associated incidental lesions not contributing to the death
(e.g., schistosomiasis). The study was mainly focussed in main
diseases causing the death (category a).
Laboratory Methods
Tissue specimens were ﬁxed in 10% buffered formalin for
2–15 d and embedded into parafﬁn wax using standard
procedures. For each sampled tissue, 4 lm sections were
stained with haematoxylin and eosin (H&E). Ancillary
histochemical and immunohistochemical stains were per-
formed to conﬁrm or exclude speciﬁc lesions suspected on
the H&E stains.
Detection of integrated HIV provirus was determined by
qualitative DNA PCR using the standard Amplicor HIV-1 kit
(Roche) on blood collected onto ﬁlter paper. In 46 women,
HIV status was assessed prior to death using the rapid test
Determine HIV (Abbot Laboratories), and positive results
were conﬁrmed with Unigold HIV (Trinity Biotech).
Malaria parasitaemia was assessed in 61 women prior to
death on thick and thin air-dried blood ﬁlms, stained with
Giemsa. A histologic evaluation of malarial pigment was done
with light microscopy under polarized light [21,22].
Definitions
Severe malaria was deﬁned as: (a) abundant sequestered
parasites in the central nervous system (CNS); (b) abundant
sequestered parasites in tissues other than the CNS and
massive haemozoin deposits in macrophages in the sinusoids
of the liver and spleen (in the absence of other causes of
death); and (c) clinical symptoms of severe malaria and
positive parasitaemias prior to death, with massive haemo-
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associated with indirect signs of severe malaria in the autopsy
(ring haemorrhages in the CNS, intravascular disseminated
coagulation, or pulmonary oedema), independent of the
presence or absence of parasites in the autopsy study. All
other cases with parasites in the autopsy or with a positive
parasitological test performed within 24 h of death and not
included in the three above-mentioned situations were
considered nonsevere active malarias. Finally, women show-
ing malarial pigment in the liver, spleen, or placenta and no
parasites were considered past infections.
All women testing positive for HIV PCR or Unigold test
were considered HIV-positive. AIDS was deﬁned by the 1993
CDC revised criteria [20].
Statistical Methods
Data were analysed with SPSS version 11 and Epi Info 6.04d.
Chi-square or Fisher exact test were used to evaluate differ-
ences in proportions between different groups. Relationships
between the prevalence of each cause of death and age and
parity were evaluated using a Chi-square test for trend.
Multinomial logistic regression analysis was done (Tables
S1 and S2). Due to small numbers in some categories and
therefore lack of statistical power it does not provide
meaningful conclusions. This type of analysis could be done
in future studies with larger sample sizes. p-Values less than
0.05 were considered signiﬁcant.
Results
General Characteristics
There were 179 maternal deaths and 21,135 live births
during the study period, resulting in a maternal mortality
ratio of 8.47 per 1,000 live births. An autopsy was done in 151
(84.3%) of the deaths. In 28 maternal deaths the family
refused to give permission for the autopsy, and another 12
were excluded because of inadequate sampling or absence of
clinical information. Nonautopsied and incomplete maternal
deaths were evenly distributed during the period of study.
Thus, 139 (77.6%) autopsied women were included in this
analysis. No differences in age were observed between women
included and excluded because of missing information.
Demographic characteristics and the pregnancy status of
the women are shown in Table 1. Mean age 6 standard
deviation was 26.1 6 6.6 y, and mean parity was 2.8 6 2.1
births.
Causes of Death
Table 2 shows the causes of death detected in the autopsies,
and Table 3 shows the distribution of causes of death by age.
The frequency of haemorrhage signiﬁcantly increased with
maternal age (Chi-squared [1 df]¼5.83; p¼0.02), whereas the
frequency of puerperal septicaemia decreased with age (Chi-
squared [1 df]¼5.57; p¼0.02). The frequency of AIDS related
conditions increased with age (Chi-squared [1 df] ¼ 3.81; p ¼
0.05), while there was a non-signiﬁcant trend for a reduced
frequency of severe malaria (Chi-squared [1 df] ¼ 3.08; p ¼
0.08) with increased maternal age (Table 3).
An HIV test was performed in 123 women, of whom 65
(52.8%) were positive. No material for HIV testing was
available for 16 women. There was no statistical correlation
between HIV infection and age: 34.5% of   20 y, 60.0% of
21–30 y, and 51.6% of . 30 y, were HIV positive, respectively
(Chi-squared [1 df] ¼ 0.07; p ¼ 0.79).
Obstetric conditions. Of those with known causes of death,
Table 1. Demographic Characteristics of the Women in the
Study
Category Group n (%)
Status of pregnancy Pregnant 35 (25.2)
Puerperium 93 (66.9)
Post-abortion 7 (5.1)
Ectopic pregnancy 2 (1.4)
Unknown 2 (1.4)
Age  20 y 32 (23.0)
21–30 y 68 (48.9)
.30 y 36 (25.9)
Unknown 3 (2.2)
Parity Primiparous 29 (20.8)
Secundiparous 19 (13.7)
Multiparous ( 3) 41 (29.5)
Unknown 50 (36.0)
Place and type of delivery Not applicable
a 44 (25.2)
Hospital vaginal 31 (22.3)
Out-of-hospital vaginal 9 (6.5)
Caesarean section 34 (24.4)
Unknown 21 (21.6)
Place of residence Maputo Centre 16 (11.5)
Maputo periphery 63 (45.3)
Rural areas 28 (20.2)
Unknown 32 (23.0)
aPatients who died during pregnancy before delivery or after abortion or ectopic
pregnancy.
doi:10.1371/journal.pmed.0050044.t001
Table 2. Causes of Death Found in the Autopsy
Category Cause n (%)
Obstetric complications Haemorrhage 23 (16.6)
Puerperal septicaemia 12 (8.7)
Eclampsia 12 (8.7)
Post-caesarean septicaemia 2 (1.4)
Ectopic pregnancy 2 (1.4)
Acute fatty liver of pregnancy 1 (0.7)
Amniotic embolism 1 (0.7)
Nonobstetric conditions HIV/AIDS-related conditions
a 18 (12.9)
Pyogenic bronchopneumonia 17 (12.2)
Severe malaria 14 (10.1)
Pyogenic meningitis 10 (7.2)
Neoplasia 4 (2.9)
Other septicaemia 3 (2.2)
Fulminant hepatitis 3 (2.2)
Decompensated cirrhosis 2 (1.4)
Mycobacterial disease 2 (1.4)
Pulmonary hypertension 2 (1.4)
Anaemia
b 1 (0.7)
Digestive haemorrhage 1 (0.7)
Alveolar proteinosis 1 (0.7)
Unknown 8 (5.8)
Total 139 (100.0)
aIncludes ten deaths with mycobacterial disease, two Kaposi sarcoma, and one malignant
lymphoma.
bClinically severe anaemia with no other cause of death and signs of cardiac failure in the
autopsy.
doi:10.1371/journal.pmed.0050044.t002
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Haemorrhage secondary to uterine atony, abruptio placen-
tae, placenta accreta, placenta previa, or that related to
uterine rupture due to obstructed labour, were the most
frequent causes of death.
Nonobstetric conditions. Of those with known causes, 78
(59.5%) women died of nonobstetric conditions (Table 2); of
these, 67 (86% [i.e., 48.2% of all autopsied deaths]) died of
infectious diseases.
HIV/AIDS-related complications were the most frequent
nonobstetric cause of death. Ten AIDS patients had myco-
bacterial disease, one had mycobacterial pneumonia, and
nine miliary mycobacteriosis, which in two women was
associated with meningoencephalitis. Mycobacterium spp. were
identiﬁed in Ziehl-Nielsen stains in all women. One woman
had a multiple infection with miliary mycobacteriosis,
pulmonary cryptococcosis, oral herpes simplex, and esopha-
gic aspergillosis. Five pneumonias due to Pneumocystis jiroveci
were identiﬁed. One of these had associated cerebral
toxoplasmosis, and another cytomegalovirus pneumonia.
Three patients had disseminated HIV/AIDS-associated neo-
plasms: two cases of Kaposi sarcoma, and a gamma-delta T
cell hepato-splenic malignant lymphoma.
The distribution of the main causes of death in the HIV-
positive and HIV-negative women is shown in Table 4. No
differences were observed between HIV-positive and -neg-
ative women in the frequency of severe malaria (Table 4), or
malaria infection (44/65 [67.7%] versus 40/58 [68.9%]; p ¼ 1).
Seventeen women (12.2%), had pyogenic bronchopneumo-
nia as a main cause of death. Severe bronchopneumonia was
identiﬁed as a ﬁnal event in two additional cases with
eclampsia.
Fourteen women (10.1%) died of severe malaria. In ﬁve of
them the diagnosis was based on the presence of abundant
sequestered parasites in the CNS; in two women it was due to
criterion (b), and in seven women it was due to criterion (c)
(see Methods section).
Four neoplasms were identiﬁed: two large meningiomas
with compressive phenomena in the CNS, one anaplastic
oligodendroglioma, and one mesenteric ﬁbromatosis with
intestinal perforation.
Two miliary mycobacteriosis were detected in HIV-
negative women. Three women with nonobstetric septicae-
Table 3. Distribution of the Causes of Death by Age
Category Cause  20 y (n ¼ 32) 21–30 y (n ¼ 68) .30 years (n ¼ 36) p-Value
a
n (%) n (%) n (%)
Obstetric complications Haemorrhage 2 (6.2) 10 (14.7) 10 (27.8) 0.02
Puerperal septicaemia 5 (15.7) 6 (8.8) 0 (0.0) 0.02
Eclampsia 4 (12.5) 5 (7.3) 3 (8.3) 0.56
Other 2 (6.2) 2 (2.9) 2 (5.6) 0.92
Nonobstetric conditions HIV/AIDS related conditions 1 (3.1) 10 (14.7) 7 (19.4) 0.05
Pyogenic bronchopneumonia 6 (18.8) 8 (11.8) 2 (5.6) 0.09
Severe malaria 5 (15.7) 8 (11.8) 1 (2.7) 0.08
Pyogenic meningitis 2 (6.2) 6 (8.8) 2 (5.6) 0.89
Neoplasia 0 (0.0) 1 (1.5) 3 (8.3) 0.04
Other 3 (9.4) 8 (11.8) 4 (11.1) 0.83
Unknown 2 (6.2) 4 (5.9) 2 (5.6) 0.90
Age was unknown in three women (one with haemorrhage, one with puerperal septicaemia and one with bronchopneumonia).
ap-Values were calculated using Chi-square for trends.
doi:10.1371/journal.pmed.0050044.t003
Table 4. Autopsy Diagnoses in HIV-Positive and HIV-Negative Women
Category Cause HIV-Positive (n ¼ 47)
a HIV-Negative (n ¼ 58) p-Value
b
n (%) n (%)
Obstetric complications Haemorrhage 5 (10.6) 12 (20.7) 0.19
Puerperal septicaemia 6 (12.9) 6 (10.3) 0.76
Eclampsia 6 (12.9) 4 (6.9) 0.33
Other 1 (2.1) 4 (6.9) 0.38
Nonobstetric conditions Pyogenic bronchopneumonia 8 (17.0) 9 (15.5) 1
Severe malaria 5 (10.6) 8 (13.8) 0.77
Pyogenic meningitis 5 (10.6) 3 (5.2) 0.46
Neoplasia 1 (2.1) 3 (5.2) 0.63
Other 5 (10.6) 6 (10.3) 1
Unknown 5 (10.6) 3 (5.2) 1
aNo blood for HIV testing was available in 16 cases; and the 18 HIV/AIDS-associated deaths are excluded from this table (see Table 2).
bp-Values were calculated using Chi-square or Fisher exact test.
doi:10.1371/journal.pmed.0050044.t004
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ovarian abscess, one to a dental abscess, and another to a
perforation of a sigmoidal diverticulitis.
Malaria parasitaemia was found in 18/61 women (29.5%)
tested before death. Histological evidence of either active or
past malaria infection was observed in 92 (66.2%) of the 139
autopsies. The frequency of the causes of death in cases with
and without histological evidence of active or past malaria
infection is shown in Table 5. In the absence of severe
malaria, none of the deaths were associated with having
current or past malaria infection.
Severe malaria was more frequent in women living in
Maputo centre or periphery (2/16 [12.5%] and 9/63 [14.3%],
respectively) than in women living in rural areas (1/28 [3.6%])
(p¼0.18). Evidence of active or past malaria was identiﬁed in
11/16 (68.7%) women living in Maputo centre, 44/63 women
living in Maputo periphery (69.8%), and 23/28 (82.1%)
women living in rural areas (p ¼ 0.44).
Severe malaria was more frequent in primiparous women
than in secundiparous and multiparous women (7/29 [24.1%];
2/19 [10.5%], and 1/41 [2.4%], respectively, p , 0.01).
Discussion
To our knowledge, this is the ﬁrst description of the causes
of maternal death in sub-Saharan Africa based on complete
autopsies. In a previous study in the same setting no CNS
examinations were conducted, thus preventing the accurate
diagnosis of cerebral malaria [4,23]. Another study in Nigeria
did not mention malaria speciﬁcally [24].
Obstetric complications accounted for 40.5% of maternal
deaths for which a cause of death could be established.
Haemorrhage represented the single most frequent cause.
Puerperal septicaemia and eclampsia were also frequent
causes of mortality. This result is in agreement with other
studies performed in developing areas [2,4,9,25]. Improved
management of the postpartum period that takes into
account well-identiﬁed risk factors and provides improved
facilities to correctly treat haemorrhages at the ﬁrst care level
could lead to a substantial reduction of maternal deaths.
Infectious diseases not directly related to the pregnancy
accounted for 48.2% of the deaths. HIV/AIDS-related
complications, pyogenic pneumonia, severe malaria, and
pyogenic meningitis were responsible for over 40% of the
maternal deaths. A striking ﬁnding was the high proportion
of women dying of pyogenic pneumonia (21.8% of those
dying of nonobstetric conditions), a condition of relatively
low case-fatality rates in adults with no other clinical
conditions (provided effective antibiotics are administered).
Thus, prompt diagnosis and adequate treatment of infectious
diseases may have a major impact on maternal mortality. HIV
testing of pregnant and puerperal women with life-threat-
ening conditions (regardless of whether or not an HIV test
was done as part of routine antenatal care) is likely to reduce
maternal mortality by improving clinician awareness of
treatable conditions such as mycobacterial and pneumocystis
infections. Mycobacterial disseminated infections were par-
ticularly common, and although mainly found in HIV-
positive patients, they were also detected in a few HIV-
negative women. A similar contribution of mycobacterial
infections to maternal mortality has been reported in two
studies on maternal mortality in Zambia and South Africa
based on clinical records [25,26].
HIV infection had a major impact on maternal mortality.
At least 12.9% of autopsied women died of diseases directly
attributable to HIV infection. Moreover, we cannot exclude
the possibility that some other infectious deaths could have
been facilitated by HIV infection. More than half (52.8%) of
the autopsied women had HIV antibodies. This prevalence is
much higher than that reported for the adult population in
Mozambique (16.2% as the average for the country and
20.7% for Maputo; unpublished data, Ministry of Health,
Mozambique, 2004). As has been observed in other sub-
Saharan countries, our results show that HIV is an important
cause of maternal mortality in this region [27,28]. Interest-
ingly, no deaths related to HIV infection were reported in
Mozambique studies in the period 1989–1993 [4,23], indicat-
ing a rapid spread of the HIV epidemic in this region [29,30].
Alternatively, this observation might be explained by less
frequent HIV testing in previous years. Thus, a substantial
reduction in maternal mortality in sub-Saharan Africa would
be achieved by increasing the uptake of HIV testing during
Table 5. Causes of Death in Cases with and without Histological Evidence of Active/Past Malaria
Category Cause Active/Past Malaria
a (n ¼ 92) No Malaria (n ¼ 47) p-Value
b
n (%) n (%)
Obstetric complications Haemorrhage (n ¼ 23) 15 (16.3) 8 (17.1) 1.00
Puerperal sepsis (n ¼ 12) 6 (6.6) 6 (12.8) 0.22
Eclampsia (n ¼ 12) 5 (5.4) 7 (14.9) 0.11
Other (n ¼ 6) 4 (4.3) 2 (4.2) 1.00
Nonobstetric conditions HIV/AIDS-related conditions (n ¼ 18) 11 (12.0) 7 (14.9) 0.60
Pyogenic bronchopneumonia (n ¼ 17) 14 (15.2) 3 (6.4) 0.17
Severe malaria (n ¼ 14) 14 (15.2) 0 (0.0) NA
Pyogenic meningitis (n ¼ 10) 8 (8.7) 2 (4.2) 0.49
Neoplasia (n ¼ 4) 2 (2.2) 2 (4.2) 0.60
Other (n ¼ 15) 8 (8.7) 7 (14.9) 0.26
Unknown (n ¼ 8) 5 (5.4) 3 (6.4) 1.00
aAll these cases showed malarial pigment in the liver and/or the spleen.
bp-Values were calculated using Chi-square or Fisher exact test.
doi:10.1371/journal.pmed.0050044.t005
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women, and preventive measures in the general population.
We did not see an association with other diseases that have
been reported to be more frequent and severe in HIV-
positive pregnant women (Table 4), such as malaria [18]. This
observation is probably due to the high prevalence of HIV in
this series and the small sample size. Malaria was a direct
cause of death in 10.1% (n ¼ 14) of women, representing the
fourth cause of death. No changes were found in the absolute
number of deaths related to malaria compared with the
period 1989–1993 [4,23]. This pattern suggests that the widely
accepted assumption that maternal deaths directly attribut-
able to malaria occur only in areas of unstable malaria
transmission [31] needs to be revised. In our study, most
deaths directly attributable to malaria occurred in women
living in urban areas where malaria endemicity is low [19],
indicating that the results for severe malaria may not be
directly extrapolated to areas of high endemicity. However,
the percentage of the population living in urban areas with
low malaria transmission but surrounded by highly endemic
areas is increasing in many developing countries. This change
may lead to increased deaths due to severe malaria in people
living in large cities. On the other hand, the observed
increased risk of severe malaria in the lower age and parity
groups, also found in a previous study in the same setting [23],
is similar to the malaria pattern in pregnancy reported from
areas of high transmission [16]. This observation suggests a
previous acquisition of immunity against malaria, and there-
fore frequent exposure to the parasite.
A possible association between eclampsia and malaria has
been reported as being more frequent in women with
malaria-infected placentas [32,33]. However, we did not ﬁnd
any such association with malaria in our series, perhaps
explained by the small number of women with eclampsia.
The maternal mortality ratio observed in our study (8.47
per 1,000 live births) is extremely high. This ratio has almost
tripled during the last decade according to data reported
from the same institution [4,23]. However, this observation
has to be taken with caution since referral facilities have
improved during this period, allowing more complicated
deliveries to reach the hospital.
The main limitation of a study based in a tertiary referral
hospital is that these results might not accurately reﬂect the
wider community. The contribution of the different causes of
death, as well as the magnitude of the maternal mortality
ratio, may differ from those observed in rural areas, since
complicated or high-risk pregnancies are referred to the
hospital. On the other hand, the toll of obstetric haemor-
rhage in rural areas might be greater than that observed in
this study, since it usually happens shortly after delivery with
little time to reach a referral hospital. More careful clinical
studies of serious illnesses in pregnant women, whenever
possible accompanied by postmortem studies in patients with
a fatal outcome (also in rural settings), are needed in
developing countries to adequately guide health professionals
and policy-makers in reducing this intolerable burden.
Infectious, treatable diseases accounted for a higher
proportion of maternal deaths than did direct obstetric
causes in this study. Thus, our ﬁndings show that there is a
potential to greatly reduce maternal mortality in sub-Saharan
Africa, not only through the improved performance of health
services for obstetric complications, but also by implement-
ing measures to adequately prevent and treat a speciﬁc group
of infectious diseases.
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Editors’ Summary
Background. Every year, half a million women—many of them living in
developing countries—die during pregnancy or childbirth or within a
few weeks of delivery. (The term ‘‘maternal deaths’’ is used to designate
such deaths.) For women living in sub-Saharan Africa, the situation is
particularly grim. Half of all maternal deaths occur in this region. The
maternal mortality ratio (MMR)—the number of maternal deaths per
100,000 live births—in sub-Saharan Africa is nearly 1,000; in industrial-
ized countries it is 8. The lifetime risk of maternal death in sub-Saharan
Africa is 1 in 22; in industrialized countries it is 1 in 8,000. Faced with the
magnitude of the global maternal death toll, in September 2000 the
United Nations pledged, as its fifth Millennium Development Goal, that
the global MMR would be reduced to a quarter of its 1990 level by 2015.
Currently, it seems unlikely that this target will be met. Between 1990
and 2005 global maternal deaths decreased by only 1% per annum. In
sub-Saharan Africa the annual reduction was even less—0.1% per
annum.
Why Was This Study Done? One reason for this slow progress is that
public-health professionals in developing countries rarely have accurate
data about the causes of maternal death, information that they need to
guide their efforts to reduce these deaths. A detailed examination of the
body after death (a medical autopsy) is the only sure way to ascertain the
causes of maternal death, but in most developing countries, clinical
records and verbal autopsies (asking relatives about the circumstances of
the mother’s death) are the main sources of these data and neither
source is optimally accurate. The currently available information
indicates that birth (obstetric) complications are the most frequent
causes of maternal death in developing countries, in particular,
hemorrhage (uncontrollable bleeding) after the baby is born. However,
little is known about the impact of the HIV/AIDS epidemic (which is
worst in Sub-Saharan Africa), malaria, or other infectious diseases on
maternal deaths. In this study, the researchers use complete autopsies to
determine the causes of maternal death in the Maputo Central Hospital,
Mozambique, a tertiary-level hospital to which women with high-risk
pregnancies are referred for specialized care.
What Did the Researchers Do and Find? Between October 2002 and
December 2004, there were 179 maternal deaths in the Maputo Central
Hospital and 31,135 live births, corresponding to a ratio of 874 maternal
deaths per 100,000 live births. (Because the hospital was a referral center,
this ratio would not be expected to reflect the actual MMR for the
general population of the Maputo area.) Complete autopsies were done
on 139 of the women, HIV infection was measured using standard tests,
and malaria was diagnosed by looking for parasites and malaria-
associated changes in postmortem samples. Of these 139 women, just
over one-third died because of obstetric complications; hemorrhage was
the most common cause of death (one in six maternal deaths). The
commonest nonobstetric causes of maternal death were HIV/AIDS-
related conditions, including infections and cancers (about 1 in 8
maternal deaths; about half the women in the study were HIV positive).
Other common causes were pyogenic (pus-forming) bacterial infections
of the lungs and brain, and malaria. Together, these infectious diseases
accounted for nearly half of the maternal deaths.
What Do These Findings Mean? These findings indicate that infectious
diseases account for a large proportion of maternal deaths at Maputo
C e n t r a lH o s p i t a la n di d e n t i f yw h ich obstetric complications are
responsible for most maternal deaths in this setting. They may not,
however, accurately reflect the causes of maternal death elsewhere in
Mozambique. For example, maternal deaths from some obstetric
complications may be over-represented in this study because women
at risk of these complications would have been referred to this hospital.
Conversely, the proportion of women dying from hemorrhage may be
higher in the community because this complication usually happens
shortly after birth, leaving little time for women to reach a hospital for
treatment. Nevertheless, these findings suggest that the implementation
of effective measures to prevent and treat HIV/AIDS, malaria, and
infections with pyogenic bacteria, together with improvements in health
services for obstetric complications, should greatly reduce the maternal
death toll in Mozambique and perhaps in other countries in sub-Saharan
Africa.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0050044.
  UNICEF (the United Nations Children’s Fund) provides information on
maternal mortality including the WHO/UNICEF/UNFPA/The World
Bank) estimates of maternal mortality for 2005 by country, and an
article on maternal mortality in the Cabo Delgado province of
Mozambique
  More information on the WHO/UNICEF/UNFPA/The World Bank
estimates of maternal mortality in 2005
  The UK Department for International Development provides informa-
tion about Millenium Development Goal 5: the improvement of
maternal health
  The US Centers for Disease Control and Prevention has a page on
pregnancy-related deaths (in English and Spanish)
  The Partnership for Maternal, Newborn and Child Health provides
information on maternal deaths (in English, Spanish, French, Russian,
Arabic, and Chinese)
  The United Nations Development Fund for Women (UNIFEM) focuses
on improving conditions for women worldwide, especially those in
poverty
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